Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.78	40.58	22.35	32.55	45.75	74.59
Short-Term Investments	-	-	80.4	65.34	-	-
Cash & Short-Term Investments	29.78	40.58	102.75	97.89	45.75	74.59
Cash Growth	-55.87%	-60.51%	4.96%	113.99%	-38.67%	660.53%
Prepaid Expenses	1.28	2.45	2.07	2.94	2.17	1.32
Total Current Assets	31.06	43.03	104.82	100.83	47.92	75.92
Property, Plant & Equipment	19.52	21.33	35.28	4.47	5.86	4.47
Other Long-Term Assets	1.99	1.99	2.5	4.67	1.09	0.45
Total Assets	52.57	66.35	142.6	109.97	54.87	80.83
Accounts Payable	0.68	1.18	3.13	2.62	3.13	0.92
Accrued Expenses	2.41	2.11	8.14	8.37	3.63	2.83
Current Portion of Leases	4.55	4.12	5.43	1.55	1.07	0.99
Current Unearned Revenue	0.03	0.4	1.66	1.28	9.79	-
Other Current Liabilities	3.49	4.82	1.23	0.66	0.63	0.15
Total Current Liabilities	11.16	12.63	19.6	14.47	18.25	4.88
Long-Term Leases	27.93	30.26	21.45	0.67	0.38	1.45
Long-Term Unearned Revenue	11.86	11.86	12.14	14.08	1.93	-
Total Liabilities	50.95	54.75	53.18	29.21	20.55	6.34
Common Stock	0	0.07	0.06	0.03	0.01	0.01
Additional Paid-In Capital	422.39	416.32	400.69	329.39	227.7	224.36
Retained Earnings	-420.77	-404.79	-311.36	-248.68	-193.4	-149.88
Comprehensive Income & Other	-	-	0.03	0.01	-	-
Total Common Equity	1.62	11.59	89.42	80.75	34.32	74.49
Shareholders' Equity	1.62	11.59	89.42	80.75	34.32	74.49
Total Liabilities & Equity	52.57	66.35	142.6	109.97	54.87	80.83
Total Debt	32.48	34.38	26.88	2.22	1.45	2.44
Net Cash (Debt)	-2.69	6.2	75.87	95.68	44.29	72.15
Net Cash Growth	-	-91.83%	-20.70%	116.01%	-38.61%	1013.14%
Net Cash Per Share	-2.04	4.76	76.17	158.22	170.54	419.98
Filing Date Shares Outstanding	1.63	1.32	1.19	0.64	0.26	0.26
Total Common Shares Outstanding	1.63	1.31	1.14	0.64	0.26	0.26
Working Capital	19.9	30.39	85.22	86.36	29.67	71.03
Book Value Per Share	1.00	8.85	78.14	126.86	131.91	288.01
Tangible Book Value	1.62	11.59	89.42	80.75	34.32	74.49
Tangible Book Value Per Share	1.00	8.85	78.14	126.86	131.91	288.01
Machinery	-	4.89	3.4	5.35	5.59	3.58
Construction In Progress	-	-	-	-	-	0.5
Leasehold Improvements	-	0.49	0.46	0.4	2.11	0.32

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q